FDA turns down Hetlioz for jet lag once again
Vanda Pharma may have forced the FDA to revisit its marketing application for Hetlioz as a therapy for jet lag, but the outcome has remained the same. Hetlioz (tasimelteon) has been approved in the US for a few years to treat sleep disorders affecting people who are blind or have the rare neurodevelopmental disorder Smith-Magenis…